In humans, a substantial proportion of tumor-infiltrating CD4 T cells express OX40, presumably due to recognition of tumor antigens, and the frequency of OX40+ CD4 T cells may be prognostic for patient outcomes (16, 17). This evidence concerns the gene TNFRSF4 and neoplasm.